The active ingredient in the drug ecstasy passed an important hurdle on the path to becoming a prescription drug for treating post-traumatic stress disorder.
The post FDA Moves Forward on Ecstasy Ingredient Trials for PTSD appeared first on Scout SEO- Melbourne Internet Marketing.
from Innovation and Digital Marketing https://www.livescience.com/60256-ecstasy-mdma-for-ptsd-treatment.html?utm_source=rss&utm_medium=rss
No comments:
Post a Comment